Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Orion Office REIT Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Orion Office REIT Inc trades at $2.19 (market cap $129.49M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 36.4× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 3.52% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Orion Office REIT Inc for 33 Days on average.
| DFTX | ONL | |
|---|---|---|
Market Cap | $4.71B | $129.49M |
Volume | 1,966,636 | 226,975 |
Sector | Health | Real Estate |
52-Week High | $48.45 | $3.00 |
52-Week Low | $10.68 | $1.93 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $3.67B | $546.42M |
Dividend Yield | — | 3.52% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Orion Office REIT (ONL) trades at $2.27, down 2.58% today, with a bearish technical signal despite recent earnings beat. The company shows deteriorating fundamentals with revenue declining from $208M in 2022 to $148M in 2025 and net losses widening to -$139M. Analyst sentiment is divided with 50% buy and 50% hold ratings, while technical indicators show mixed signals with moving averages bearish but oscillators bullish.
ONL presents a high-risk opportunity with deep value metrics (P/S 0.9, P/B 0.2) but significant operational challenges. The office REIT faces structural headwinds with negative profitability and declining revenue, though strategic repositioning efforts and potential AI-driven office demand could offer upside. Investors should weigh the attractive valuation against persistent losses and office sector challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
